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Abstract
Autophagy may be involved in gestation complicated by preeclampsia (PE) due 
to the presence of placental lesions caused by hypoxia at fetomaternal interphase. 
Autophagy is a lysosomal degradation pathway, removing protein aggregates and 
organelles damaged and thereby maintaining cell integrity. In preeclampsia, defi-
cient myometrial penetration by extravillous cytotrophoblast occurs during the first 
trimester of pregnancy, leading to placental insufficiency. Several placental func-
tions, like nutrient and oxygen input to the fetus during pregnancy, might benefit or 
even rely on autophagy and related material recycling within the cell. Deficiency in 
autophagy mechanism has been correlated to inflammatory responses. Autophagy is 
regulated during placentation and appears to be a possible factor in the development of 
preeclampsia. In this chapter, we intend to discuss evidence on autophagy pathway in 
pregnancy and the crosstalk between autophagy and inflammation in preeclampsia.
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1. Introduction
Autophagy is an intracellular degradation system conserved among eukaryotes 
[1] characterized as a natural defense mechanism capable to reduce damages related 
to inflammatory responses and infectious, neoplasia and degenerative diseases. 
Defects in this process are directly linked to several diseases [2, 3]. The main role of 
autophagy is to maintain cellular homeostasis by recycling intracellular materials. 
Cells under starvation or with organelle damage trigger the autophagy mechanism 
in order to clean their cytoplasm and restore a source of energy [4–6].There are 
three types of autophagy: microautopahgy, chaperone-mediated autophagy, and 
macroautophagy [7]. The most characteristic process of autophagy is the macro-
autophagy. This process is characterized by the creation of a double membrane 
compartment in the cytoplasm called phagophore. This structure develops into an 
autophagosome, a double lipid bilayer membrane-bound structure. The autophago-
some merges with lysosomes leading to the autolysosome formation. Continuing 
the process of autophagy, the autolysosome is finally degenerated, releasing in the 
cytosol a number of monomers that can be reused by the cell as important sources 
of energy (Figure 1) [8, 9].
The beginning of the autophagy process is dependent on the inhibition of the 
mammalian target of rapamycin (mTOR) and then autophagy proteins become 
crucial to the completion of the cascade generated [5, 10]. In this manner, cells 
under sufficient nutrition or without structural damages maintain a state of activa-
tion of mTOR, keeping blocked the mechanism of autophagy. After being trig-
gered, mTOR provides a catalytic subunit by two distinct multiprotein complexes, 
Prediction of Maternal and Fetal Syndrome of Preeclampsia
2
mTORC1 (mechanistic target of rapamycin complex 1), and mTORC2 (mechanistic 
target of rapamycin complex 2). Some proteins are common for both complexes 
(GβL and Deptor), but others reflect specific functions for each of them, as rap-
tor for mTORC1 and rictor for mTORC2 [11]. Regarding functions, mTORC1 
coordinates the synthesis of lipids and proteins to promote cell growth, while 
mTORC2 acts in the cytoskeletal actin control [12]. Therefore, mTORC1 complex 
finally establishes the autophagy process via ULK1 (mammalian ortholog of yeast 
autophagy-related gene 1) kinase activity. The process of autophagosome formation 
involves about 38 Atgs (autophagy-related genes), and the initial process of autoph-
agy in mammals is controlled by Atg1/ULK complex, which consists in ULK1/2 
(UNC-51-like kinase 1), mAtg13, FIP200 (interaction protein of 200KD, homolog 
of the yeast Atg17), and Atg101. During nutrient rich conditions or in the pres-
ence of cell integrity, mTORC1 phosphorylates and inhibits ULK1/2 and mAtg13, 
deregulating the contact between ULK and AMPK (AMP-activated protein kinase), 
a kinase with activation effect on ULK1. But under altered conditions, mTORC1 is 
inhibited, and the activation of ULK1/2 leads to phosphorylation and activation of 
mAtg13 and FIP200 [13].
Atg plays crucial roles as ubiquitin-like protein conjugation system that mediates 
protein lipidation and participation in autophagy-specific protein kinase com-
plexes [14, 15] for accomplishment of autophagy. Atg1 and Atg12-Atg5 complexes 
are essential for the autophagic machinery. Another important gene is Atg8 (a 
yeast autophagy-related gene ortholog of LC3), a membrane marker during the 
formation of autophagosome. Atg9 transmembrane protein and regulators of its 
trafficking (Atg2 and Atg18) participate in the expansion of phagophore after the 
formation of the Atg1 complex. There are two systems, Atg12 (Atg5, Atg7, Atg10, 
Atg12, and Atg16) and Atg8 (Atg3, Atg4, Atg7, and Atg8), which are responsible for 
expansion of the vesicle [1, 16].
The establishment of the autophagy is also dependent of two proteins: beclin-1 
protein and LC3 (light chain protein 3) [17, 18]. Beclin-1 (homolog of yeast Apg6/
Vps30) promotes the recruitment of membranes to form the autophagosome, 
nucleation of the autophagic vesicle, and recruitment of proteins from the cytosol 
[19]. Three isoforms of LC3 have been described: LC3A, LC3B, and LC3C. After 
synthesis and activation (LC3-I to LC3-II), LC3-II for incorporating cytosolic 
denatured proteins and damaged organelles into the autophagosome [20, 21]. The 
relative amounts of LC3-II reflect autophagic activity [22]. Considering the autoph-
agy pathway, LC3-II has been proposed to be used to measure autophagy activity. 
Figure 1. 
Autolysosome formation. The process starts with a development of a double membrane named phagophore. 
This structure develops into an autophagosome, merging with lysosomes to form the autolysosome. During the 
process of autophagy, the autolysosome is degraded, releasing monomers into the cytosol, which can be reused by 
the cell as a source of energy. Source: own authorship.
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Defective autophagy caused by mutations or genetic alterations can lead to various 
clinical syndromes [23], such as static encephalopathy of childhood with neurode-
generation in adulthood (SENDA), Vici syndrome, hereditary spastic paraparesis, 
Parkinson’s disease, lysosomal storage disorders, cancer, and Crohn’s disease.
As a lysosomal degradation pathway, removing protein aggregates and organ-
elles damaged, maintaining cell integrity, autophagy may be impaired in pregnant 
women with preeclampsia (PE) due to the presence of placental lesions caused by 
hypoxia/ischemia [24]. In preeclampsia, there is deficient myometrial penetration 
by extravillous cytotrophoblast during the first trimester of pregnancy, leading to 
placental insufficiency [25]. On the other hand, it has been reported that proteins 
related to autophagy, LC3-II, and beclin-1 are present in trophoblastic villi during 
normal pregnancy, and high levels of LC3-II are present in the placenta of pregnant 
women with severe preeclampsia [26]. The induction of hypoxia on choriocarci-
noma cell line JEG-3 with the purpose of exploring the mechanism of regulatory 
proteins involved in autophagy showed a slight increase in the expression of LC3-II, 
with a reduction in beclin-1. Treatment of these cells with TNF-α induced a sig-
nificant increase in the expression of LC3-II without modifying the expression of 
beclin-1. The results suggest that the increased autophagic activity mediated by 
LC3-II may be involved in the pathophysiology of preeclampsia [26].
Studies with autophagy in the placenta are scarce, and most of the work done 
employs cell lines or cultures of trophoblast cells in vitro to evaluate autophagy 
induced by nutrient deprivation and oxygen [27].
The systemic inflammatory response exacerbated in preeclampsia seems to be 
related to the release of substances capable of inducing inflammation as membrane 
fragments of syncytiotrophoblast, fetal DNA, soluble microparticles derived from 
leukocytes, and inflammatory cytokines in plasma of pregnant women, causing 
activation of cells of innate immunity [28–30]. Other cellular components pres-
ent in plasma, such as protein derivatives, polysaccharides, and lipids, as well as 
extracellular matrix products are named “damage-associated molecular patterns” 
(DAMPS) and are considered important modulators of the inflammatory response. 
DAMPs are represented by molecules like uric acid, reactive oxygen intermediates, 
heat shock proteins (Hsp) [31], proteins released from dead cells, as the high mobil-
ity group box 1—HMGB1 [32], and products released from the extracellular matrix, 
such as fibronectin and hyaluronan [33, 34]. Both protein hsp70 [35, 36] and 
hyaluronan [37, 38] are elevated in plasma of pregnant women with preeclampsia 
and may be associated with systemic inflammation and oxidative stress. However, 
the role of these factors in the pathophysiology of preeclampsia is not well under-
stood. A major cause of preeclampsia is the accumulation of reactive oxygen species 
(ROS), resulting in impaired antioxidant protection and activation of autophagy. 
According to research in trophoblasts, expression of LC3 and beclin-1 and the 
formation of autophagosomes are higher than in normal placentas, suggesting that 
autophagy is regulated during placentation and appears to be a possible factor in the 
development of preeclampsia [39].
2. Autophagy and placenta
The placental development requires multiples roles of autophagy. Experimental 
studies suggest that autophagy plays important functions in survival of neonates 
during nutritional deficiency at the early stage of birth [40]. Moreover, it was seen 
that the growth and remodeling of cervical fascia progress by autophagy regula-
tion. Meanwhile, it has not been reported that autophagy affects differentiation 
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of trophoblasts in pregnant women by LC3-II and beclin-1, markers which are 
analyzed and compared between term placentas, and in their first trimester of 
gestation [39]. Autophagy is essential for placental development and for maintain-
ing pregnancy, and the disruption of autophagy in extravillous trophoblast (EVT) 
contributes to hypoplastic placentation. Placentas of patients with preeclampsia 
present high levels of autophagy, with lower LC3 activation, and higher apoptosis 
than normal pregnancies. When induced by external factors such as hypoxia, 
autophagy directly affects trophoblast infiltration during normal placental 
 development [41].
The study of autophagy markers in preeclampsia demonstrated that there are 
different patterns during normal pregnancy and preeclampsia, in part, because 
of the environmental factors, like hypoxia. Cells exposed to hypoxic conditions 
demonstrated higher levels of LC3, beclin-1, and the autophagosome formation 
when compared to normal placentas. Saito and Nakashima [24] reported that poor 
placentation is induced by decreased infiltration of trophoblasts due to abnor-
mal processing for autophagy, which is activated by soluble endoglin (sENG). 
Inactivation of autophagy represses trophoblast infiltration and vascular remodel-
ing due to excessive hypoxia, causing poor placentation, as observed in preeclamp-
sia [26]. Hung and collaborators showed that autophagy decreased with advancing 
of gestational age in placentas of normotensive women, through analyses of changes 
in LC3-II and p62 according to gestational weeks [42].
The determination of p62 levels also has a few reports and in addition with the 
analysis of LC3-II [2, 14, 43] may be important to determine autophagic status in 
the villous tissue.
This important finding has been the basis of several investigations on oxida-
tive stress, an alteration identified in placental related disorders, and whether this 
oxidative stress is able to induce autophagy activation on placental explants. We 
developed an in vitro study with the objective of evaluating the effect of oxida-
tive stress induced by hydrogen peroxide (H2O2) on the occurrence of autophagy 
activation in placental explants of pregnant women at term (39–40 weeks), without 
clinical or obstetric disorders identified and undergone to elective cesarean section. 
In the methodology, we intended to reproduce experimentally the pathophysiol-
ogy of obstetric complications related to placental dysfunction caused by uterine 
circulatory alterations. These alterations are responsible for the establishment of the 
hypoxia-reoxygenation phenomenon also called as ischemia-reperfusion injury and 
consequent production of (ROS).
The results showed the higher gene expression of LC3-II, beclin-1, and p62 
detected in cultures exposed to different concentrations of H2O2 and demonstrated 
that the oxidative stress generated was able to induce autophagy in placental 
explants (Figure 2). Material and methods of this experiment are shown as supple-
mentary material to this chapter.
Gene expression of LC3-II (Figure 2A) was increased in tissues exposed to the 
concentration of 1000 μM of H2O2 compared to the non-exposed cultures, which 
means that autophagy was more activated in this concentration, in response to the 
oxidative effect. Gene expression of beclin-1 and p62 (Figure 2B and C) increased 
in front of increasing concentrations of H2O2 with the maximum value in 1000 μM 
of H2O2, showing statistical difference (p < 0.05) when compared to controls.
In the present study, the higher gene expression of LC3-II, beclin-1, and p62 
detected in cultures exposed to H2O2 demonstrated that the oxidative stress gener-
ated was able to induce autophagy in placental explants.
The high expressions of mRNA for LC3-II and TNF-α (Figure 3A and B) 
demonstrated in our study corroborate with other reports, showing that placental 
5Autophagy in Preeclampsia
DOI: http://dx.doi.org/10.5772/intechopen.85592
Figure 2. 
Activation of autophagy in cultures exposed to different concentrations of hydrogen peroxide. mRNA expression 
of LC3-II (A), beclin-1 (B), and p62 (C) in placental explants. Results expressed as mean ± SD. * (p < 0.05) vs. 
0; # (p < 0.05) vs. 0, 10, 100 μM (ANOVA). Source: own authorship.
Figure 3. 
Pro-inflammatory cytokine profile in cultures exposed to different concentrations of hydrogen peroxide. Gene 
and protein expression of pro-inflammatory cytokines TNF-α(A/B) and IL-1β (C/D) in placental explants. 
Results expressed as mean ± SD. * (p < 0.05) vs. 0 (ANOVA). Source: own authorship.
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hypoxic environment and the presence of TNF-α caused a positive regulation in the 
autophagy-related protein LC3-II in a trophoblastic cell line [26].
Gene expressions of TNF-α and IL-1β were higher in explants cultured with 
1000 μM of H2O2 with significant difference (p < 0.05) to culture without H2O2 
(Figure 3A and C). The protein expressions of these cytokines (Figure 3B and D) 
were higher in the supernatants from concentrations of 100 to 1000 μM of H2O2, 
with difference (p < 0.05) to non-exposed and cultures with 10 μM of H2O2. The 
protein expression of IL-1 β was higher in 1000 μM of H2O2 (p < 0.05) than in the 
culture of 100 μM of H2O2 (Figure 3D).
The similar patterns of p62, beclin-1, and LC3-II gene expressions suggest the 
production of mRNA for the p62 protein transcription, which will be degraded 
during autophagy activation. This protein plays a significant role on the regulation 
of oxidative stress, degenerative diseases, and carcinogenesis [44].
3. Autophagy and inflammasomes
Inflammasome is a molecular platform composed of nucleotide-binding oligo-
merization domain (NOD)-like receptor (NLR) proteins. It is required for the acti-
vation of caspase-1 and subsequent maturation of the pro-inflammatory cytokines 
interleukin-1β and IL-18 [45]. NLRs respond to different endogenous or exogenous 
stimuli and activate caspase-1. During inflammation, these pro-inflammatory 
molecules are maturated in inflammasomes, which are in part regulated by the 
autophagy mechanism.
Actually, autophagy can control endogenous inflammasome activators, such as 
pro-IL-1β, which regulates the secretion of IL-1β and IL-18, thereby preventing an 
exaggerated inflammation [9, 45, 46].The activation of the inflammasome NLRP3 
occurs via two signals: the first signal is provided by NF-kB activators and is a 
prerequisite for inflammasome activation via NLRP3 expression in macrophages 
[47]; the second signal activates NLRP3 inflammasome directly and involves 
host-derived adenosine triphosphate (ATP), uric acid crystals, bacterial toxins, or 
particulate matter (Figure 4) [48].
Some studies have demonstrated a mutual relationship between autophagy 
and inflammasomes. Autophagy negatively regulates inflammasome activation. 
Autophagy induction is dependent on the presence of specific inflammasome sen-
sors, inflammasomes are ultimately degraded by autophagosomes via the selective 
autophagic receptor p62, and autophagy plays a role in the biogenesis and secretion 
of the pro-inflammatory cytokine IL-1β [45, 9, 49].
The role of autophagy in inflammasome regulation may depend on the 
context of danger signal. In the absence of a danger signal, autophagy can act 
removing IL-1β and inflammasome components while maintaining cellular 
homeostasis. In the presence of a danger signal, autophagy may act initially 
as a secretory pattern to diffuse inflammation while preventing cell death and 
pyroptosis. Recent studies showed that macrophages may activate autophagy in 
response to inflammasome activation, as a way to delay the onset of pyroptosis. 
According to the authors, the inhibition of autophagy resulted in increased 
activation of pyroptosis and the impact of these types of cell death regulation by 
autophagy need to be more studied on inflammatory process [50]. When genes 
of autophagy regulator Atg 16L1 or Atg7 are deleted or a chemical inhibitor of 
autophagy is applied, LPS-dependent inflammasome activation occurs suggest-
ing that autophagy controls inflammasome activation and can limit production 
of cytokines IL-1β and IL-18 [51]. Induced autophagy to inhibit the inflamma-
some and excessive inflammation or marking directly specific NLRs (NOD-like 
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receptors) to reduce its activity may be a promising strategy to reverse inflamma-
tory process [52].
In the present study, the oxidative stress induced by H2O2 on placental 
explants contributed to the inflammatory profile generated by activating  
the NLRP3 inflammasome, caspase-1 and inducing the release of IL-1β  
(Figure 3C and D).
In a previous study published by our research group, we observed that some 
markers of oxidative stress, such as superoxide dismutase (SOD) and catalase are 
altered at high concentrations of hydrogen peroxide confirming that H2O2 induces 
oxidative stress on placental explants and demonstrated that this stress involves 
inflammasome activation [53].
We demonstrated that gene expressions of NLRP3 and caspase-1 have similar 
patterns, with greater expression in cultures exposed to the concentration of 
1000 μM of H2O2, which means that this concentration was able to activate the 
NLRP3 inflammasome (Figure 5). The activation of this complex may occur as a 
Figure 4. 
Activation of NLRP3 inflammasome. This process requires two signals: the first is dependent of NF-kB 
activators and the second demands ATP, uric acid crystals, bacterial toxins or particulate matter to activate 
NLRP3 inflammasome. Source: own authorship.
Figure 5. 
Inflammasome activation in placental explants in cultures exposed to different concentrations of hydrogen 
peroxide. mRNA expression of NLRP3 (A) and caspase-1 (B) in explants of placental explants. Results 
expressed as mean ± SD. * (p < 0.05) vs. 0, 10 μM (ANOVA). Source: own authorship.
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consequence of a common form of cellular stress initiated by different stimuli, such 
as the release of ROS [54, 55].
The relationship between occurrence of inflammasome and autophagy activa-
tion may be explained by the elevation in gene expression of p62 under conditions 
of oxidative stress. Inflammasome can be degraded by autophagosomes through this 
protein [56].
4. Conclusion
Taken together, the results of the present study confirm that H2O2 induces 
oxidative stress in placental explants, demonstrated by activation of NLRP3 
inflammasome, which in turn induce the autophagy activation in order to control 
the inflammatory state. Activation of inflammasome and autophagy are essential 
elements of the innate immune system, and disorders in these processes have been 
implicated in various inflammatory and infectious diseases [57]. Oxidative stress 
may also contribute to placental tissue senescence and to the pathophysiology of 
some placental-related disorders of pregnancy, such as preeclampsia and fetal 
growth restriction [56]. Thus, initiatives to reduce stress on trophoblastic tissue 
should be considered for future researches.
Many studies have observed the effects of supplementation to prevent the effects 
of oxidative stress and autophagy in preeclampsia, such as the use of antioxidants, 
vitamins C and E, calcium, resveratrol and some natural products [58–61].
The use of natural products and hormones such as Vitamin D may be a new 
model to reduce inflammation by regulating autophagy, since there is a direct 
correlation between vitamin D levels and cell survival in pathologies associated 
with gestation. Vitamin D and its components such as vitamin D receptor (VDR) 
are molecules that are highly related to the autophagic process [62]. In this sense, 
the use of products with antioxidant and anti-inflammatory effects still need to be 
evaluated in order to reduce oxidative stress, induce autophagy, and decrease the 
activation of inflammasome in placental tissue.
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1. Material and methods
1.1 Study population and ethics statement
This study consisted of 15 healthy pregnant women with normal evolution of the 
pregnancy, with no personal history of hypertensive disorders in pregnancy. These 
pregnant women were admitted to the Obstetrics Unit of Botucatu Medical School, 
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Sao Paulo State University, Botucatu, SP, Brazil between November 2015 and May 
2016. Gestational age was calculated from the last menstrual period and confirmed 
by ultrasound dating. Exclusion criteria included chronic hypertension, multiple 
gestation, prior preeclampsia, illicit drug use, and preexisting medical conditions 
such as diabetes, cancer, acute infectious disease, cardiovascular, autoimmune, 
renal and hepatic diseases. The study was approved by the Ethics Committee of 
the Botucatu Medical School, and written informed consent was obtained from all 
women involved in the study (CAAE Protocol number: 37160614500005411).
1.2 Collection of placental tissue
All placentas from normotensive pregnant women were delivered by cesarean 
section, without labor and were examined macroscopically and processed within 
10 min of delivery. Fragments of approximately 5 × 5 cm were immediately removed 
from the central region of the placenta, constituting samples of the villous cytotro-
phoblast and the syncytiotrophoblast region in contact with the maternal side (basal 
plate). After collection, the trophoblastic tissue was washed in buffered saline (PBS) 
and separated from the decidual layer that is normally adhered to the basal plate. 
The terminal portions of the villi were evidenced in PBS (the villi were seen floating 
freely in the liquid) and dissected in small sections to constitute explants.
1.3 Culture of placental explants with hydrogen peroxide
The amount of villi used was 11 mg of placental tissue that was cultured in each 
well of 24-well plates (SPL Life Sciences, Korea) for 24 h for stabilization [63]. 
Cultures were performed in vitro in the absence of hydrogen peroxide or in the pres-
ence of 10, 100, and 1,000 μM of H2O2 for 4 h and 24 h in RPMI 1640 culture medium 
supplemented with 2 mM L-glutamine (Sigma-Aldrich, St Louis, MO, USA), 40 mg/ml  
antibiotic/antimycotic (Sigma-Aldrich), and 10% fetal bovine serum (Gibco BRL Life 
Technologies, The Netherlands) inactivated (complete RPMI medium).
After the culture periods, the explants were removed and submitted to RNA 
extraction for further analysis of the expression of genes related to inflammation 
(cytokines), autophagy, and inflammasome. Culture supernatants were obtained, 
centrifuged at 2,000 g for 10 min and stored at −80°C for determination of cytokines.
1.4 Cell viability assay
The cell viability assay was conducted through the activity of the enzyme lactate 
dehydrogenase (LDH) in supernatants of placental explant after 24, 48, 72, and 
96 h of culture and was determined by commercial kit (Sigma-Aldrich) according 
to the manufacturer’s instructions.
1.5 Evaluation of the expression of transcripts related to inflammation
The placental explants were evaluated for the expression of the genes encod-
ing IL-1β, TNF-α, LC3-II, beclin-1, and p62 proteins at the transcriptional level. In 
addition, the gene expression of the inflammasome was evaluated through the NLRP3 
and caspase-1 genes. Total RNA was extracted from the placentas using the Total RNA 
Purification Kit (Norgen Biotek Corp., Thorold, Canada) according to the manufac-
turer’s protocol, and the Reverse Transcription-coupled polymerase chain reaction 
(RT-qPCR) was performed as described previously [64]. Briefly, isolated RNA was 
DNAse I Amp Grade (Invitrogen) treated. Subsequently, the synthesis of complemen-
tary DNA (cDNA) was conducted using ImProm-IITM Reverse Transcription System, 
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according to manufacturer’s protocol. The RT-qPCR was made using RT GoTaq-qPCR 
Master Mix (Promega, Madison, WI, USA), and the primer sequences used in this 
study are listed in Table 1. Each reaction was set in duplicate and the conditions for 
the RT-qPCR were as follows: initial denaturation at 96°C for 2 min and then 40 cycles 
at 95°C for 15 s and 60°C for 60 s, followed by a melting curve. Expression values of 
the analyzed transcripts were normalized to that of the enzyme-encoding glyceralde-
hyde-3-phosphate dehydrogenase gene (GAPDH).
The calculation of the differential expression of selected genes was carried out 
by the data processing method compared with a standard curve [65]. To analyze 
relative gene expression, we standardized the RNA expression levels in all samples 
to that of a single RNA sample, which was set to a value of 100.
1.6 Cytokine determination
Cytokine concentrations in culture supernatants of placental explants were 
determined by enzyme-linked immunosorbent assay (ELISA), using Quantikine 
Gene Sequence (5′-3′) Name GeneBank
Caspase-1 Forward primer: (1065)
AGACATCCCACAATGGGCTC(1084)
Reverse primer: (1172)
TGAAAATCGAACCTTGCGGAAA(1151)
CASP1 NM_033292.3
NLRP3 Forward primer: (2826)
GAGGAAAAGGAAGGCCGACA(2845)
Reverse primer: (2917)
TGGCTGTTCACCAATCCATGA(2897)
NLRP3 NM_004895.4
IL-1β Forward primer: (544)
GAGCAACAAGTGGTGTTCTCC(564)
Reverse primer: (653)
AACACGCAGGACAGGTACAG(634)
IL1B NM_000576.2
TNF-α Forward primer: (325)
GCTGCACTTTGGAGTGATCG(344)
Reverse primer: (462)
GGGTTTGCTACAACATGGGC(443)
TNF NM_000594.3
p62 Forward primer: (159)
CGCTTCAGCTTCTGCTGC(176)
Reverse primer: (308)
GTCCTCATCGCGGTAGTGC(290)
SQSTM1 NM_003900.4
Beclin-1 Forward primer: (101)
GTAGACCGGACTTGGGTGAC(120)
Reverse primer: (198)
CATGGTGCTGTTGTTGGACG(179)
BECN1 NM_003766.3
LC3-II Forward primer: (517)
CCAGGAAACCTTCGGCTTCT(536)
Reverse primer: (632)
CGGTAGAGGCAGCTCAGTTC(613)
MP1LC3A NM_032514.3
GAPDH Forward primer: (684)
CGTGGAAGGACTCATGACCA(703)
Reverse primer: (801)
GGCAGGGATGATGTTCTGGA(782)
GAPDH NM_002046.4
Table 1. 
Primers for inflammasome and autophagy proteins, cytokines, and GAPDH. Source: Gen Bank (https://www.
ncbi.nlm.nih.gov/genbank).
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ELISA kits (R&D Systems) for TNF-α and IL-1β according to the manufacturer’s 
instructions. Assay sensitivity limits were 1.6 pg./mL for TNF-α and 3.9 pg./mL for 
IL-1β.
1.7 Statistical Analysis
All of the data were analyzed using one-way ANOVA, followed by post-hoc 
Tukey test using the statistical program PRISM (Graph Prism for Windows, version 
6.01, GraphPad, EUA) to compare the difference among the groups. A p value less 
than 0.05 was considered to be statistically significant.
Key points
1. Autophagy is an intracellular degradation system characterized as a natural 
defense mechanism capable to reduce damages related to inflammatory 
responses.
2. The main role of autophagy is to maintain cellular homeostasis by recycling 
intracellular materials.
3. Activation of inflammasome and autophagy are essential elements of the 
innate immune system, and disorders in these processes have been implicated 
in various inflammatory and infectious diseases.
4. Oxidative stress may also contribute to placental tissue senescence and to the 
pathophysiology of some placental-related disorders of pregnancy, such as 
preeclampsia and fetal growth restriction.
5. The use of products with antioxidant and anti-inflammatory effects still need 
to be evaluated in order to reduce oxidative stress, induce autophagy, and 
decrease the activation of inflammasome in placental tissue.
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